Release Date: 16/03/09 08:21 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 1.2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%